Sunday, August 19, 2018 12:21:42 PM
https://greatercannabiscompany.com/faqs/
July 11, 2018 Update
On July 9, 2018, the Company was notified that FINRA had passed on the Company’s Form 211 application and set July 10, 2018 as the date its stock would begin being quoted under the symbol “GCAN.” So what does a shareholder need to do at this point to sell their shares:
(i) If your shares are held at a broker dealer such as Etrade, Schwab, TD Ameritade, Scottrade, Interactive Brokers or any other online broker, you will need to contact the Company to ask them to place a “sell” order. The shares on deposit at the broker dealer have a restrictive legend on them that is to be removed with the “Effectiveness” of the Company’s Registration Statement and subsequent Post-Effective Amendment to the Registration Statement. The Registration Statement has a legal opinion which accompanies it opining on the shares. Each broker dealer may handle the transaction differently, but in short they will be required to send the certificate with the restrictive legend to the Company’s transfer agent and request that a new certificate without restrictive legend be returned. We highly recommend that you contact a representative at your broker dealer in an effort to help expedite the process. Most have been extremely slow in handling the transaction which has delayed trading.
(ii) If you are holding “in hand” the certificate issued in the stock dividend, you will need to send the certificate to the Company’s transfer agent and request that a new certificate without restrictive legend be issued.
Transfer Agent:
Pacific Stock Transfer
6725 Via Austi Pkwy, Suite 300
Las Vegas, NV 89119
(800) 785-7782
*Disclosure: My posts are solely for entertainment purposes; mainly my own. Do not take my posts as a recommendation or solicitation to trade any securities. Do your own Due Diligence (DD).
Recent GCAN News
- Form PRER14C - Information statements • Edgar (US Regulatory) • 02/26/2024 09:09:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:37:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 04:03:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 10:11:59 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM